Related Experiment Video
Updated: Mar 22, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
Published on: June 14, 2019
Association Between Hepatitis C Virus and Head and Neck Cancers
Parag Mahale1, Erich M Sturgis1, David J Tweardy1
1Affiliations of authors: Department of Infectious Diseases, Infection Control, and Employee Health (PM, DJT, EJAH, HAT), Department of Head and Neck Surgery (EMS), Department of Epidemiology (EMS), and Department of Molecular and Cellular Oncology (DJT), The University of Texas MD Anderson Cancer Center, Houston, TX; Department of Epidemiology, Human Genetics & Environmental Sciences, The University of Texas School of Public Health, Houston, TX (PM).
Hepatitis C virus (HCV) is linked to specific head and neck cancers (HNCs), particularly nonoropharyngeal and HPV-positive oropharyngeal types. This study investigated the association between HCV infection and HNC development.
Area of Science:
- Oncology
- Virology
- Epidemiology
Background:
- Hepatitis C virus (HCV) infection is a known risk factor for certain cancers, including hepatocellular carcinoma and non-Hodgkin's lymphoma.
- MD Anderson observed a high prevalence of head and neck cancers (HNCs) among HCV-infected patients, prompting further investigation.
- The association between HCV and HNCs requires detailed examination to understand potential links.
Purpose of the Study:
- To determine if Hepatitis C virus (HCV) seropositivity is associated with an increased risk of developing head and neck cancers (HNCs).
- To investigate the specific subtypes of HNCs that may be linked to HCV infection.
- To explore potential correlations between HCV, human papillomavirus (HPV), and HNC development.
Main Methods:
- A case-control study was conducted using medical records of cancer patients tested for HCV antibodies between 2004 and 2014.
- Case subjects included patients with new-onset primary oropharyngeal or nonoropharyngeal HNCs; control subjects had smoking-associated cancers.
- Multivariable logistic regression models were used to analyze the association between HCV seropositivity and HNCs, with adjustments for relevant factors.
Main Results:
- The prevalence of HCV seropositivity was significantly higher in patients with nonoropharyngeal HNCs (20.0%) and HPV-positive oropharyngeal cancers (16.9%) compared to control subjects (6.5%).
- Adjusted analyses revealed a statistically significant association between HCV seropositivity and nonoropharyngeal HNCs (OR = 2.85) and HPV-positive oropharyngeal cancers (OR = 2.97).
- HCV was found to be associated with nonoropharyngeal HNCs (excluding nasopharyngeal) and HPV-positive oropharyngeal HNCs.
Conclusions:
- Hepatitis C virus (HCV) is associated with an increased risk of developing nonoropharyngeal (excluding nasopharyngeal) and HPV-positive oropharyngeal head and neck cancers.
- Further research is warranted to elucidate the interaction between HCV and HPV in the context of HNC development.
- The findings suggest a potential role for HCV in the etiology of specific HNC subtypes, necessitating further investigation into HPV-related malignancies.
Related Concept Videos
Hepatitis
Mechanisms of Retrovirus-induced Cancers
Mechanisms of Retrovirus-induced Cancers
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
Cytomegalovirus Disease

